RRC ID 62177
著者 Ohashi N, Kodera Y, Nakanishi H, Yokoyama H, Fujiwara M, Koike M, Hibi K, Nakao A, Tatematsu M.
タイトル Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice.
ジャーナル Int J Oncol
Abstract To explore the effect of chemotherapy against peritoneal micrometastases, we used in vivo models of peritoneal micrometastasis featuring three human gastric cancer cell lines tagged with the green fluorescence protein gene. With a highly metastatic cell line, GCIY-EGFP, the survival rate of mice treated with weekly intraperitoneal paclitaxel starting one day following inoculation was significantly higher than those of control mice or mice given the same treatment starting on day eight. Intravenous paclitaxel exhibited no significant survival benefit regardless of the treatment schedule. Pharmacokinetic analysis revealed that the concentration of paclitaxel in the metastatic nodules treated with intraperitoneal administration was 2-3-fold higher than those treated with intravenous paclitaxel, provided the treatment was given on day one. Even greater responses were observed with less aggressive MKN28-EGFP and MKN45-EGFP cell lines, whose peritoneal metastases resolved completely due to early intraperitoneal treatment in 13 of the 14 mice tested. These results indicate that intraperitoneal paclitaxel is effective against peritoneal metastasis in early phase.
巻・号 27(3)
ページ 637-44
公開日 2005-9-1
PMID 16077911
MeSH Animals Antineoplastic Agents, Phytogenic / administration & dosage* Antineoplastic Agents, Phytogenic / pharmacokinetics Antineoplastic Agents, Phytogenic / therapeutic use Cell Line, Tumor Green Fluorescent Proteins / genetics Green Fluorescent Proteins / metabolism Humans Immunohistochemistry Injections, Intraperitoneal Injections, Intravenous Male Mice Mice, Nude Neovascularization, Pathologic / metabolism Neovascularization, Pathologic / pathology Paclitaxel / administration & dosage* Paclitaxel / pharmacokinetics Paclitaxel / therapeutic use Peritoneal Neoplasms / drug therapy* Peritoneal Neoplasms / mortality Peritoneal Neoplasms / secondary Plasmids / genetics Platelet Endothelial Cell Adhesion Molecule-1 / analysis Stomach Neoplasms / drug therapy* Stomach Neoplasms / genetics Stomach Neoplasms / pathology Survival Analysis Survival Rate Transfection Treatment Outcome Xenograft Model Antitumor Assays / methods
IF 3.899
リソース情報
ヒト・動物細胞 MKN45(RCB1001)